SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer.
Yu P, He W, Zhang Y, Hu C, Wu Y, Wang Y, Bao Z, Xia Y, Zhang R, Cao M, Yuan L, Cheng X, Xu Z.
Yu P, et al. Among authors: yuan l.
J Oncol. 2022 Jul 5;2022:8829649. doi: 10.1155/2022/8829649. eCollection 2022.
J Oncol. 2022.
PMID: 35847366
Free PMC article.